Modern trends in the development of bacterial vaccines for human use. 1988

K D Hungerer, and L Robbel
Research Laboratories of Behringwerke AG, Marburg, W.-Germany.

The development of vaccines against infectious diseases is one of the great medical achievements of the 20th century. What other medical measure had such an influence on the statistical prolongation of life, as the use of vaccines did? The successful development of today's vaccines was from the beginning due to the intensive cooperation between the basic research sciences (e.g. bacteriology virology, chemistry, immunology) and the applied sciences (e.g. medicine-practiced). During the last few years newly developed techniques have awakened hopes for the development of new vaccines which are better tolerable and more effective. Molecular biologic methods have shown first successes in the development of epitope vaccines. Monoclonal anti-idiotype antibodies are being used in active protection experiments. Modern galenic preparations can perhaps one day replace the parenteral administration of antigens. In the following some of the new techniques are listed and their significance for the development of new vaccines discussed.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D014614 Vaccines, Synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens, Synthetic,Chemical Vaccine,Chemical Vaccines,Immunogens, Synthetic,Molecular Vaccine,Molecular Vaccines,Recombinant Vaccine,Semisynthetic Vaccine,Semisynthetic Vaccines,Synthetic Antigen,Synthetic Vaccine,Synthetic Vaccines,Vaccines, Recombinant,Synthetic Antigens,Synthetic Immunogens,Vaccines, Chemical,Vaccines, Molecular,Vaccines, Semisynthetic,Antigen, Synthetic,Recombinant Vaccines,Vaccine, Chemical,Vaccine, Molecular,Vaccine, Recombinant,Vaccine, Semisynthetic,Vaccine, Synthetic

Related Publications

K D Hungerer, and L Robbel
March 1982, Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete,
K D Hungerer, and L Robbel
January 1983, Zeitschrift fur Erkrankungen der Atmungsorgane,
K D Hungerer, and L Robbel
November 1993, Veterinary microbiology,
K D Hungerer, and L Robbel
February 2000, Current opinion in molecular therapeutics,
K D Hungerer, and L Robbel
September 2020, Nederlands tijdschrift voor geneeskunde,
K D Hungerer, and L Robbel
August 1981, Zeitschrift fur arztliche Fortbildung,
K D Hungerer, and L Robbel
March 2021, World journal of microbiology & biotechnology,
K D Hungerer, and L Robbel
January 1996, Developments in biological standardization,
K D Hungerer, and L Robbel
February 1985, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale B, Hygiene,
K D Hungerer, and L Robbel
December 1979, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Copied contents to your clipboard!